John Kelly

Founder, Managing Director, Chief Executive / Atomo Diagnostics

For over 20 years, John Kelly was into developing and commercialising medical devices to enhance usability and performance, having started with CR Bard in Europe developing Class III implantable cardiology products.

Prior to co-founding Atomo in September 2009, Mr Kelly acted as the chief operating officer of Unilife Corporation which was previously an ASX-listed company and subsequent to his departure, a Nasdaq-listed company. At Unilife Corporation, he led the global operations team from 2005 to 2008, developing 'Unifill'. Prior to Unilife in 2005, Mr Kelly spent five years at ResMed where he led the new product implementation group and managed the development of Mirage Swift & Activa mask systems.

Lists and Charts

Roles

2009

Founder, Managing Director, Chief Executive

Atomo Diagnostics

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
969^th	Stockland Baldivis	-9.33%	7.6%
970^th	Ampol	-9.33%	1.71%
971^st	Atomo Diagnostics	-9.38%	0%
972^nd	APA Group	-9.51%	-3.01%
973^rd	Middle Island Resources	-9.52%	-32.64%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Founder, Managing Director, Chief Executive, Atomo Diagnostics

03 Nov 2020

Related Information

Access to our data for John Kelly is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

John Kelly is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.